Application of Gold Nanorods for Plasmonic and Magnetic Imaging of Cancer Cells

Plasmonics

Volumn 6, Issue 1, 2011, Pages 105-112

  Liu, Liwei ^a,b,c   Ding, Hong ^b,c   Yong, Ken Tye ^b,c   Roy, Indrajit ^b,c   Law, Wing Cheung ^b,c   Kopwitthaya, Atcha ^b   Kumar, Rajiv ^b   Erogbogbo, Folarin ^b   Zhang, Xihe ^a,c   Prasad, Paras N ^b,c  

^a CHANGCHUN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c Changchun University of Science and Technology   (China)

Author keywords

Cancer; Dark field imaging; DOTA; Gd; Gold nanorods; MRI

Indexed keywords

EID: 79953025841     PISSN: 15571955     EISSN: 15571963     Source Type: Journal    
DOI: 10.1007/s11468-010-9175-2     Document Type: Article

References (51)

1. Prasad PN (2003) Wiley-Interscience, New York.
2. Prasad PN (2004) Wiley-Interscience, New York.
3. Ferrari M (2005) Nat Rev Cancer 5: 161-171.
4. Whitesides GM (2005) Small 1: 172-179.
5. Lim YT, Noh Y-W, Cho J-H, Han JH, Choi BS, Kwon J, Hong KS, Gokarna A, Cho Y-H, Chung BH (2009) J Am Chem Soc 131: 17145-17154.
6. Hadjipanayis CG, Bonder MJ, Balakrishnan S, Wang X, Mao H, Hadjipanayis GC (2008) Small 4: 1925-1929.
7. Hsiao J-K, Tsai C-P, Chung T-H, Hung Y, Yao M, Liu H-M, Mou C-Y, Yang C-S, Chen Y-C, Huang D-M (2008) Small 4: 1445-1452.
8. Zheng J, Jaffray D, Allen C (2009) Mol Pharm 6: 571-580.
9. Kim D, Jeong YY, Jon S (2010) ACS Nano 4: 3689-3696.
10. Wu W, Li R, Bian X, Zhu Z, Ding D, Li X, Jia Z, Jiang X, Hu Y (2009) ACS Nano 3: 2740-2750.
11. Kim D, Park S, Lee JH, Jeong YY, Jon S (2007) J Am Chem Soc 129: 7661-7665.
12. Glaus C, Rossin R, Welch MJ, Bao G (2010) Bioconjug Chem 21: 715-722.
13. Law W-C, Yong K-T, Roy I, Ding H, Hu R, Zhao W, Prasad PN (2009) Small 5: 1302-1310.
14. Yong K-T, Roy I, Ding H, Bergey EJ, Prasad PN (2009) Small 5: 1997-2004.
15. Erogbogbo F, Yong K-T, Roy I, Xu G, Prasad PN, Swihart MT (2008) ACS Nano 2: 873-878.
16. Félidj N, Laurent G, Grand J, Aubard J, Lévi G, Hohenau A, Aussenegg F, Krenn J (2006) Plasmonics 1: 35-39.
17. Emerich DF (2005) Expert Opin Biol Ther 5: 1-5.
18. Sullivan DC, Ferrari M (2004) Nanotechnology and tumor imaging: seizing an opportunity. In: Molecular imaging, B. C. Decker Inc.
19. Weissleder R (2001) Nat Biotech 19: 316-317.
20. Law W-C, Yong K-T, Roy I, Xu G, Ding H, Bergey EJ, Zeng H, Prasad PN (2008) J Phys Chem C 112: 7972-7977.
21. Kumar R, Nyk M, Ohulchanskyy TY, Flask CA, Prasad PN (2009) Adv Funct Mater 19: 853-859.
22. Yong KT (2009) Nanotechnology 20: 15102.
23. Sokolov K, Follen M, Aaron J, Pavlova I, Malpica A, Lotan R, Richards-Kortum R (2003) Cancer Res 63: 1999-2004.
24. Mitamura K, Imae T (2009) Plasmonics 4: 23-30.
25. Ghosh P, Han G, De M, Kim CK, Rotello VM (2008) Adv Drug Deliv Rev 60: 1307-1315.
26. Huang X, Jain PK, El-Sayed IH, El-Sayed MA (2007) Nanomedicine 2: 681-693.
27. Stone JW, Sisco PN, Goldsmith EC, Baxter SC, Murphy CJ (2006) Nano Lett 7: 116-119.
28. Sonavane G, Tomoda K, Makino K (2008) Colloids Surf, B 66: 274-280.
29. Kopwitthaya A, Yong K-T, Hu R, Roy I, Ding H, Vathy LA, Bergey EJ, Prasad PN (2010) Nanotechnoloy 21: 315101.
30. Zhu J, Yong K-T, Roy I, Hu R, Ding H, Zhao LL, Swihart MT, He GS, Cui YP, Prasad PN (2010) Nanotechnology 21: 285106.
31. Law W-C, Yong K-T, Baev A, Hu R, Prasad PN (2009) Opt Express 17: 19041-19046.
32. Yong K-T, Swihart M, Ding H, Prasad P (2009) Plasmonics 4: 79-93.
33. Jain P, Huang X, El-Sayed I, El-Sayed M (2007) Plasmonics 2: 107-118.
34. Sando G, Berry A, Campbell P, Baronavski A, Owrutsky J (2007) Plasmonics 2: 23-29.
35. Mustafa D, Yang T, Xuan Z, Chen S, Tu H, Zhang A (2010) Plasmonics 5: 221-231.
36. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD (2005) Small 1: 325-327.
37. Ding H, Yong K-T, Roy I, Pudavar HE, Law WC, Bergey EJ, Prasad PN (2007) J Phys Chem C 111: 12552-12557.
38. Popovtzer R, Agrawal A, Kotov NA, Popovtzer A, Balter J, Carey TE, Kopelman R (2008) Nano Lett 8: 4593-4596.
39. Hu R, Yong K-T, Roy I, Ding H, He S, Prasad PN (2009) J Phys Chem C 113: 2676-2684.
40. Calzolari A, Finisguerra V, Oliviero I, Deaglio S, Mariani G, Malavasi F, Testa U (2009) Blood Cells, Molecules, and Diseases 42: 5-13.
41. Hirsch L, Gobin A, Lowery A, Tam F, Drezek R, Halas N, West J (2006) Ann Biomed Eng 34: 15-22.
42. Huang X, Jain P, El-Sayed I, El-Sayed M (2008) Lasers Med Sci 23: 217-228.
43. Huang H-C, Barua S, Kay DB, Rege K (2009) ACS Nano 3: 2941-2952.
44. Huang H-C, Rege K, Heys JJ (2010) ACS Nano 4: 2892-2900.
45. Norman RS, Stone JW, Gole A, Murphy CJ, Sabo-Attwood TL (2007) Nano Lett 8: 302-306.
46. Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Mol Pharm 5: 505-515.
47. Boyd BJ (2008) Expert Opin Drug Deliv 5: 69-85.
48. Burtea C, Laurent S, Elst L, Muller RN (2008) Contrast agents: magnetic resonance. Handb Exp Pharmacol 185: 135-165.
49. Frullano L, Meade T (2007) J Biol Inorg Chem 12: 939-949.
50. Lanza GM, Winter PM, Caruthers SD, Morawski AM, Schmieder AH, Crowder KC, Wickline SA (2004) J Nucl Cardiol 11: 733-743.
51. Link S, Burda C, Nikoobakht B, El-Sayed MA (2000) J Phys Chem B 104: 6152-6163.